StoxRadar is free — only 218 spots left in beta.

SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%SPY$777.22-0.24%QQQ$757.73-0.25%DIA$511.02-0.69%IWM$277.70-1.29%AAPL$336.67+0.91%MSFT$529.76+0.09%NVDA$237.47-0.74%AMZN$259.92+1.42%GOOGL$350.50+0.81%META$721.31-2.38%TSLA$377.81-0.75%JPM$329.58-0.51%GLD$375.88-1.67%BTC$36.88-2.54%IBIT$47.21-2.64%

StoxRadar is free.

APUS

APUS

AMEX

Apimeds Pharmaceuticals US, Inc

Healthcare · Biotechnology

$7.05
-0.08-1.12%
Day Range: $6.86 – $9.84
Market Cap
$10.64M
Volume
22.33M
52W High
$59.70
52W Low
$1.51
P/E Ratio
-0.14
EPS (TTM)
$-35.63
Div Yield
—
Beta
0.15

Price History

08-2609-0309-1409-2209-30$0$2$4$6$8

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

CEO
Vinod Menon
Employees
7
Headquarters
Matawan, US
IPO Date
2025-05-09
BETA

Get started for full access.